JMD Association for Molecular Pathology 2008 Annual Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J.
Right arrow Articles by Hashimoto, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J.
Right arrow Articles by Hashimoto, H.
JMD 2000, Vol. 2, No. 1
Copyright © 2000 American Society for Investigative Pathology & Association for Molecular Pathology

COL1A1-PDGFB Fusion Transcripts in Fibrosarcomatous Areas of Six Dermatofibrosarcomas Protuberans

Jian Wang*{ddagger}, Yosuke Morimitsu*, Sumika Okamoto*, Masanori Hisaoka*, Tsuyoshi Ishida{dagger}, Weiqi Sheng*{ddagger} and Hiroshi Hashimoto*

From the Department of Pathology and Oncology, * School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan; the Department of Pathology, {dagger} Faculty of Medicine, University of Tokyo Hospital, Tokyo, Japan; and the Department of Pathology, {ddagger} Cancer Hospital, Shanghai Medical University, Shanghai, People’s Republic of China

The fibrosarcomatous transformation of dermatofibrosarcoma protuberans (DFSP) has been considered for some time to be associated with an adverse clinical outcome. However, the molecular and cellular mechanism underlying the tumor progression remains undetermined. As the chimeric gene, COL1A1-PDGFB, has been proposed to play an important role in the histogenesis of DFSP, we conducted a reverse transcription-polymerase chain reaction assay to ascertain whether the COL1A1-PDGFB fusion transcripts can be detected in both conventional DFSP and fibrosarcomatous components of DFSP with fibrosarcomatous areas (DFSP-FS), using a simple method of microdissection on sections of archival formalin-fixed, paraffin-embedded tumor specimens from six DFSP-FS cases. The COL1A1-PDGFB fusion transcripts could be detected in FS areas in five of the six cases, whereas conventional DFSP areas of all cases expressed the chimeric mRNA. A subsequent sequence analysis of the polymerase chain reaction products confirmed that the detected messages were derived from identical gene fusions in the two different components of each of the five cases. Our results verify that the COL1A1-PDGFB fusion transcripts are preserved in the FS areas of most DFSP-FSs. The expression of the fusion transcripts in both conventional DFSP and FS areas of DFSP-FS supports a common histogenesis of the two components.




This article has been cited by other articles:


Home page
JCOHome page
D. Kerob, F. Pedeutour, C. Leboeuf, O. Verola, E. de Kerviler, J. M. Servant, F. Sarandi, G. Bousquet, I. Madelaine-Chambrin, C. Pruvost, et al.
Value of Cytogenetic Analysis in the Treatment of Dermatofibrosarcoma Protuberans
J. Clin. Oncol., April 1, 2008; 26(10): 1757 - 1759.
[Full Text] [PDF]


Home page
Arch DermatolHome page
G. Maire, S. Fraitag, L. Galmiche, F. Keslair, N. Ebran, M.-J. Terrier-Lacombe, Y. de Prost, and F. Pedeutour
A Clinical, Histologic, and Molecular Study of 9 Cases of Congenital Dermatofibrosarcoma Protuberans
Arch Dermatol, February 1, 2007; 143(2): 203 - 210.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
Z. Szollosi, B. Scholtz, K. Egervari, and Z. Nemes
Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas
J. Clin. Pathol., February 1, 2007; 60(2): 190 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
W Gu, A Ogose, H Kawashima, H Umezu, N Kudo, T Hotta, and N Endo
Congenital dermatofibrosarcoma protuberans with fibrosarcomatous and myxoid change
J. Clin. Pathol., September 1, 2005; 58(9): 984 - 986.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
H. Tsao
Genetics of Nonmelanoma Skin Cancer
Arch Dermatol, November 1, 2001; 137(11): 1486 - 1492.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology and the Association for Molecular Pathology.